Tempus AI Buys Personalis for $1.5 Billion
A massive consolidation in cancer diagnostics reveals the steep financial price of dominating the liquid biopsy market.
July 21, 2026
Follow us
latest articles
Discover the newest research about AI innovations in 👤 Personalized Medicine.
AI synthetic patients successfully replace real trial controls
A new study shows AI-generated synthetic patients can replicate cancer trial results, potentially shrinking the need for human control groups.
July 17, 2026
AI adapts genetic risk scores for diverse ancestries
A new deep learning tool bypasses the need for massive non-European genetic trials by adapting existing risk models to diverse populations.
July 16, 2026
AI Tool Predicts Cancer Survival From Single Cells
Averaging tumor data has long blinded oncologists to the specific, high-risk cells that drive patient mortality.
July 14, 2026
ML predicts fertility-sparing treatment success in cancer
A new machine learning model uses simple blood and nutrition markers to predict which uterine cancer patients can safely skip aggressive surgery to preserve their fertility.
July 13, 2026
AI predicts brain bleed survival without brain scans
A new machine learning model predicts 30-day mortality for brain bleed patients using routine clinical data instead of expensive brain scans, challenging the assumption that advanced imaging is required for accurate prognosis.
July 13, 2026
AI Predicts Veteran Mortality Using Outpatient Billing Codes
A new model bypasses complex clinical charts to predict long-term death risk using nothing but raw billing codes.
July 12, 2026
AI blood test spares women invasive cancer scans
A new AI-driven blood test could soon keep thousands of women out of the imaging room by ruling out womb cancer with near-perfect accuracy.
July 9, 2026
AI Predicts Fractures Using Patient History Trajectories
Static bone density scans miss how a patient’s body changes over time, but a new deep learning model proves that tracking those physical trajectories can prevent missed fracture risks.
July 8, 2026
Digital Twins Solve Rare Disease Trial Dilemma
Using virtual clones to simulate disease progression could finally solve the recruitment bottleneck that stalls rare disease drug development.
July 5, 2026